Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer
Authors:
Open Access
- 20 January 2023
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 31, 383-397
Abstract
No abstract availableKeywords
Funding Information
- Office of Research Infrastructure Programs (UG3 TR002852)
- National Institutes of Health (R01 AI116698)
- National Institutes of Health (1S10OD028536-01)
This publication has 74 references indexed in Scilit:
- Impact of VP1-Specific Protein Sequence Motifs on Adeno-Associated Virus Type 2 Intracellular Trafficking and Nuclear EntryJournal of Virology, 2012
- An RNA Alternative to Human Transferrin: A New Tool for Targeting Human CellsMolecular Therapy Nucleic Acids, 2012
- Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particlesVirology, 2011
- Mutagenesis of Adeno-Associated Virus Type 2 Capsid Protein VP1 Uncovers New Roles for Basic Amino Acids in Trafficking and Cell-Specific TransductionJournal of Virology, 2010
- In vivo selection of tumor-targeting RNA motifsNature Chemical Biology, 2009
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated VirusesJournal of Virology, 2008
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer CellsCancer Research, 2008
- Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy VectorJournal of Virology, 2007
- Heparan Sulfate Proteoglycan Binding Properties of Adeno-Associated Virus Retargeting Mutants and Consequences for Their In Vivo TropismJournal of Virology, 2006
- Liver Transduction with Recombinant Adeno-Associated Virus Is Primarily Restricted by Capsid Serotype Not Vector GenotypeJournal of Virology, 2006